Cataract surgery and co-existing glaucoma: Expert insight on phaco-plus procedures

Written by: Mr Chrysostomos Dimitriou
Published:
Edited by: Sophie Kennedy

In this informative article, we hear expert insight from revered consultant ophthalmic surgeon Mr Chrysostomos Dimitriou on simultaneous cataract and glaucoma micro-incisional and minimally invasive surgery for patients suffering from both eye conditions concurrently. Mr Dimitriou, a highly respected specialist in cataract surgery and glaucoma management also details the most common causes of blindness in over fifties worldwide and explains how innovation in the field is improving outcomes for patients.

How do glaucoma and cataract affect our vision?

Glaucoma, also known as the “silent thief of vision” is a progressive damage to the optic nerve, the cable that connects the back of the eye to the brain. It usually affects peripheral visual function, so-called “tunnel vision”, thus for example “stealing” patients’ driving eligibility and subsequent licence at advanced disease stages. It may also lead to serious partial or total loss of central vision, which is irreversible, if left untreated for too long. Lowering the pressure inside the eye, a major risk factor for glaucoma progression, is the main target of all currently available anti-glaucoma treatment modalities.

Cataract is the clouding of the normally clear natural lens of the eye, simulating vision while looking through a frosty or fogged-up window. When our vision is clouded by cataracts, it is more difficult to read, drive a car (particularly at night) or distinguish expressions on people's faces. Cataract surgery, the most common operation performed worldwide amongst all medical specialties, has been successfully addressing this problem with very high safety profile and patient satisfaction for decades.

Nowadays, the growing and ageing of populations have led to increasing numbers of individuals with moderate to severe vision impairment globally. These trends triggered World Health Organisation and the International Agency for the Prevention of Blindness to establish an initiative in 1999 named 'Vision 2020: The Right to Sight'. In 2020, the leading global causes of blindness in those aged 50 or over were identified as:

  • Cataract: 15.2 million cases
  • Glaucoma: 3.6 million cases
  • Under-corrected refractive error: 2.3 million cases
  • Age-related macular degeneration: 1.8 million cases
  • Diabetic retinopathy: 0.86 million cases

​Of those cases, glaucoma is the primary cause of irreversible visual loss worldwide.


What are the latest treatment modalities?

As modern, micro-incisional, ultrasonic (phacoemulsification) and laser-assisted cataract surgery has evolved over the recent years, a new era of minimally invasive glaucoma (MiGS) procedures (micro-pulse lasers, micro-stents, micro-tubes and micro-shunts) has arisen. The eruption of those MiGS technologies has evidently increased the treatment options and therapeutic approaches to tackling intraocular pressure control (IOP) at the time of cataract surgery, in one combined operation.

At The Oaks Private Hospital, as well as The Colchester Eye Centre of Excellence, a significant proportion of the globally available MiGS have become routine practice of phaco-plus procedures, meaning cataract surgery combined with a glaucoma operation in less than half an hour on the operating table, under local or topical anaesthesia, significantly reducing IOP, as well as the burden of topically applied anti-glaucoma eye-drops on a daily basis.




Mr Dimitriou is a senior full-time consultant ophthalmologist and the lead clinician for glaucoma at his NHS base and has performed in excess of 2000 MiGs procedures. He is currently recognised as the eye surgeon with the highest number of successful MiGS procedures in the whole of East Anglia to include SLT Laser, Micro-Pulse Laser, XEN45, iStent G2W, KDB, PRESERFLO, HYDRUS, OMNI and many more.

Mr Dimitriou was awarded Level 2 Clinical Excellence Award in 2019 in acknowledgement of his efforts to bring those new technologies to everyday clinical practice for the benefit of his cataract and glaucoma patients. To schedule a consultation with Mr Dimitriou, visit his Top Doctors profile.

By Mr Chrysostomos Dimitriou
Ophthalmology

Mr Chrysostomos Dimitriou is an award-winning, substantive consultant ophthalmic surgeon, specialising in modern cataract surgery and glaucoma therapy, as well as all general eye conditions. He regularly performs small-incision phacoemulsification and femto-laser assisted cataract surgery (>33-40 operations per week) both routine and advanced in near-sighted and short-sighted eyes with small pupils, angle closure, narrow chambers, and co-existing glaucoma.

Mr Dimitriou is the lead clinician for cataract and glaucoma at the OAKS Hospital in Colchester, as well as East Suffolk and North Essex NHS Foundation Trust (ESNEFT) for Private Patients. He has performed in excess of 12,000 cataract operations and 3,000 MiGS procedures (minimally invasive glaucoma surgery) and is currently recognised as the eye surgeon with the highest number of successful MiGS procedures in the whole of East Anglia to include SLT laser, micro-pulse laser, XEN45, iStent G2 w inject, KDB, PRESERFLO, HYDRUS, OMNI, iTRACK Advance, TrabEx+, MINIject, MiMS, and more recently excimer laser trabeculostomy (ELiOS), one of the first surgeons in the country to adopt those new technologies.

Mr Dimitriou regularly offers combined cataract and glaucoma procedures with micro-stents, micro-catheters and lasers to relieve the burden of glaucoma eye-drops. He performed the first ever XEN45 glaucoma sub-conjunctival micro-stent implantation at Essex County Hospital (15.6.2016@ECH), Baerveldt glaucoma tube implantation (19.4.2017@ECH), CyPass glaucoma supraciliary micro-stent implantation (22.11.2017@ECH) and i-Stent G2 glaucoma trans-trabecular micro-stent implantation (6.12.2017@ECH).

Mr Dimitriou completed comprehensive training at The Royal United Hospital in Bath, The Prince Charles Eye Unit in Windsor and The Royal Surrey County Hospital (RSCH) in Guildford (2007-2012). He received further sub-specialty training at Norfolk and Norwich University Hospital and the world-renowned Moorfields Eye Hospital in London (2012-2015). He has also completed a full-year fellowship in MIGS at RSCH (2016-2017).

Mr Dimitriou serves as principal investigator for major glaucoma research studies, including the National East Anglian POEM Study, International XEN45 in Angle Closure Multi-Centre Study, Pan-European MASTERS CyPass Study, TRITON, ARTEMIS, ATHENA Bimatoprost slow-release implant trials and more recently STAR VI and STAR LiFE trials for MINIject supraciliary glaucoma implants.

Mr Dimitriou has featured twice on the Daily Mail for his contributions to modern cataract and glaucoma surgery and is lecturing around the world on a regular basis, whilst publishing his research and audit results in peer reviewed journals. Mr Dimitriou, senior full-time consultant ophthalmologist, also serves as the surgical tutor and MiGS simulation lead for the Royal College of Ophthalmologists in Colchester and ESNEFT. He has been awarded a Level 2 Clinical Excellence Award (2019) in acknowledgment of his efforts to bring those new treatment modalities to everyday clinical practice for the benefit of his cataract and glaucoma patients. He has also been presented with the 2023 Rob Brierly Educational Award by ESNEFT as the Top Medical Trainer for the Trust in acknowledgement of his tireless efforts to educate and support the next generation of ophthalmologists and eye surgeons in the East of England and beyond.

View Profile

Overall assessment of their patients


  • Related procedures
  • Microdermoabrasion
    Microneedling
    Dark circles
    Mesotherapy
    Facelift
    Neck lift
    Botulinum toxin (Botox™)
    Dermal fillers
    Peeling
    Facial paralysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.